Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 27 Nov 2024
PTC Therapeutics Enters into Agreement to Sell Priority Review Voucher for $150 Million
PTC Therapeutics Enters into Agreement to Sell Priority Review Voucher for $150 Million
HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
HSMN NewsFeed - 22 Nov 2024
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
HSMN NewsFeed - 7 Nov 2024
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
HSMN NewsFeed - 23 Oct 2024
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer